Precision Medicine Group

Clinical research and commercialization services provider

Appears in 1 story · Last updated Aug 26, 2026

Stories

McKesson agrees to buy Precision Medicine Group in $2.25B deal

Money Moves

As of August 2026: Acquisition target of McKesson

The largest US drug distributor, McKesson, agreed on August 25 to buy Precision Medicine Group for $2.25 billion. Precision runs clinical trials, biomarker labs, and payer-negotiation services for biotechnology and pharmaceutical companies.

Updated Aug 26